A carregar...
Drug resistance to targeted therapies: Déjà vu all over again
A major limitation of targeted anticancer therapies is intrinsic or acquired resistance. This review emphasizes similarities in the mechanisms of resistance to endocrine therapies in breast cancer and those seen with the new generation of targeted cancer therapeutics. Resistance to single‐agent canc...
Na minha lista:
| Publicado no: | Mol Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528618/ https://ncbi.nlm.nih.gov/pubmed/24910388 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2014.05.004 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|